OneSource Specialty Pharma shares rose nearly 14% after the company reported Q2 revenue growth of 37% year-on-year and adjusted profit after tax of ₹93.7 crore. The company maintained its FY28 targets and expects expanded drug-device combination capacity to support future growth.
OneSource Specialty Pharma shares rose nearly 14% after the company reported Q2 revenue growth of 37% year-on-year and adjusted profit after tax of ₹93.7 crore. The company maintained its FY28 targets and expects expanded drug-device combination capacity to support future growth.
<iframe src="https://hindustansphere.com/embed/cluster/6187c744f4b274cccfcb5bc6b0f24509c82eb322" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="OneSource Specialty Pharma shares jump 14% after Q2 results; recover 50% from recent lows"></iframe>
